The Board of Regents of the Nevada System of Higher Education on Behalf of the University of Nevada; Las Vegas
发明人:
Ernesto Abel-Santos,Amber Howerton
申请号:
US14798276
公开号:
US09862744B2
申请日:
2015.07.13
申请国别(地区):
US
年份:
2018
代理人:
摘要:
A method of treating a patient to reduce risk of developing Clostridium difficile-associated disease or reducing existing Clostridium difficile-associated disease in a mammalian subject involves administering to a mammalian subject an effective amount of a germination-inhibiting compound derived from taurocholate. Novel compounds of this class are also provided.